Plasma cell myeloma diagnosed in pregnancy

Case report OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-16 ⓘ

Plasma cell myeloma is an incurable B cell disorder characterized by bone marrow failure, renal failure, and bone pain, with a median survival of five years.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Plasma cell myeloma (PCM) is an essentially incurable neoplastic disorder of terminally differentiated B cells. The neoplastic clone usually secretes a monoclonal protein in the serum or urine (the 'M band'). About 20% of PCM secrete light chains only, which are detectable in the urine as Bence Jones protein. The clinical picture is one of bone marrow failure, due to infiltration of the marrow by malignant plasma cells; renal failure due to damage to renal tubules by the excess light chains and pain due to lytic lesions of the bones. The outcome remains poor with median survival of 5 years.

My notes (saved in your browser only)

MeSH descriptors

Multiple Myeloma Pregnancy Complications, Neoplastic Adult Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols Biopsy, Needle Bone Marrow Bone Marrow Cesarean Section Disease Progression Female Fetal Growth Retardation Fetal Growth Retardation Hematopoietic Stem Cell Transplantation Humans Infant, Newborn Male Multiple Myeloma Multiple Myeloma Multiple Myeloma

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:10:37.302907+00:00
unpaywall
last seen: 2026-10-31T06:28:23.984441+00:00